ScreenCell® enables rapid, reliable, and cost-effective isolation of circulating tumor cells (CTCs) from a simple blood sample.
We are transforming circulating tumor cell research into concrete solutions to improve cancer patient care.
+90%
Circulating Tumor Cells (CTC) recovery rate.
Explore the full range of ScreenCell® CTC isolation kits, each specifically designed to meet the diverse needs of liquid biopsy applications.
FCD
Blood sample
< 3 days
or
Cells fixed detached
from the isolation support for analysis in suspension or on slide
FCD-SP
Blood sample
< 4 hours
or
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
Explore over 70 scientific articles authored by our customers and partners.
You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.
Follow ScreenCell® on LinkedIn
